Leaflet: information for the user

Mirtazapina Flas Bluefish 30 mg buccal dispersible tablets EFG

mirtazapina

Read this leaflet carefully before you start taking this medicine, as it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, consult your doctor, pharmacist or nurse.
• This medicine has been prescribed for you only. Do not give it to others, even if they have the same symptoms as you, as it may harm them.
• If you experience any side effects, consult your doctor, pharmacist or nurse, even if they are not listed in this leaflet. See section 4.

1. What is Mirtazapina Flas Bluefish 30 mg buccal dispersible tablets and what it is used for

2. What you need to know before you start taking Mirtazapina Flas Bluefish 30 mg buccal dispersible tablets

3. How to take Mirtazapina Flas Bluefish 30 mg buccal dispersible tablets

4. Possible side effects

5. Storage of Mirtazapina Flas Bluefish 30 mg buccal dispersible tablets

6. Contents of the pack and additional information

Mirtazapina FlasBluefish belongs to a group of medicines called antidepressants.This medicineis used to treat depression in adults. It takes 1 to 2 weeks for mirtazapina to start working. After 2 to 4 weeks you may start to feel better. You should consult your doctor if you get worse or do not improve after 2 to 4 weeks.For more information see section 3 "When you can expect to feel better".

Do not take Mirtazapina Flas Bluefish

if you are allergic to mirtazapina or any of the other ingredients (listed in section 6).if you are taking or have taken in the last two weeks certain medicines called monoamine oxidase inhibitors (MAOIs).

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to take Mirtazapina Flas Bluefish.

DO NOT TAKE OR CONSULT YOUR DOCTOR BEFORE STARTING TO TAKE mirtazapina: If you have ever had a severe skin rash or peeling of the skin, blisters, or mouth sores after taking mirtazapina or other medicines.

Children and adolescents

Mirtazapina Flas Bluefish should not normally be used in the treatment of children and adolescents under 18 yearsbecause its efficacy has not been demonstrated.At the same time, it should be noted that in patients under 18 years there is an increased risk of adverse effects such as suicidal attempts, suicidal ideas, and hostility (predominantly aggression, confrontational behavior, and irritability) whenthey ingest this type of medication. Although, the doctor who is responsible for you may prescribe Mirtazapina Flas Bluefish to patients under 18 years when they decide what is best for the patient. If the doctor who is responsible for you has prescribed Mirtazapina Flas Bluefish to a patient under 18 years and wants to discuss this decision, please return to your doctor. You should inform your doctor if any of the symptoms listed above progress or if you experience complications when patients under 18 years are taking

Mirtazapina Flas Bluefish. At the same time, the long-term effects regarding safety and related to growth, maturity, and cognitive and behavioral development of Mirtazapina Flas Bluefish in this age group have not yet been demonstrated.It has also been observed more frequently a considerable weight gain in this age group when treated with mirtazapina, compared to adults.

Thoughts of suicide and worsening of your depression:

If you feel depressed, you may sometimes have ideas of harming yourself. This can happen especially when you start taking antidepressants, as these medicines usually take about two weeks to take effect and sometimes longer.

You shouldtake the following into account:

• If you have previously had ideas of suicide or self-harm.
• If you are an adult young persontake note that information from clinical trials has shown an increase in the risk of suicidal behavior in adults under 25 years with psychiatric conditions treated with an antidepressant.

• If at any time you have thoughts of harming or killing yourself,consult your doctor or go to the hospital immediately.

It may be helpful to tell a close relative or friendthat you feel depressed and ask them to read this leaflet. They may ask if they think your depression or anxiety is getting worse or if they are concerned about changes in your behavior.

Also, be especially careful with Mirtazapina Flas Bluefish:

• If you have or have had any of the following conditions.

Inform your doctor about these situations before taking Mirtazapina Flas Bluefish, if you have not already done so.

−seizures(epilepsy). If seizures occur or your seizures are more frequent, stop taking Mirtazapina Flas Bluefish and contact your doctor immediately;

−liver diseases, including jaundice. If jaundice appears, stop taking Mirtazapina Flas Bluefish and contact your doctor immediately;

−kidney diseases;

−heart diseaseorlow blood pressure;

−schizophrenia. If psychotic symptoms, such as paranoid thoughts, are more frequent or severe, contact your doctor immediately;

−bipolar depression(periods of excitement/hyperactivity and periods of depression alternate). If you start to feel excited or overexcited, stop taking Mirtazapina Flas Bluefish and contact your doctor immediately;

−diabetes(you may need to adjust your insulin dose or other diabetes medicines);

−eye diseases, such as increased pressure in the eye (glaucoma);

−difficulty urinating, which may be due to an enlarged prostate;

−certain types of heart diseasethat may change your heart rhythm, a recent heart attack, heart failure, or taking certain medicines that may affect your heart rhythm.

• If you develop signs of infection such as unexplained high fever, sore throat, and mouth ulcers.

→ Stop taking Mirtazapina Flas Bluefish and consult your doctor immediately for a blood test.

These symptoms may be in rare cases signs of alterations in blood cell production in the bone marrow. Although rare, these symptoms may appear more frequently 4-6 weeks after treatment.

-Severe skin reactions have been reported with the use of mirtazapina, such as Stevens-Johnson syndrome (SSJ), toxic epidermal necrolysis (NET), and drug reactions with eosinophilia and systemic symptoms (DRESS). Discontinue use and seek medical attention immediately if you notice any of the symptoms described in section 4 related to these severe skin reactions.

If you have ever had severe skin reactions, do not restart treatment with Mirtazapina Bluefish.

• If you are an elderly person. You may be more sensitive to the adverse effects of antidepressant medicines.

Other medicines and Mirtazapina Flas Bluefish

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.

Do not takeMirtazapina Flas Bluefish with:

Examples of MAOIs are moclobemida, tranilcipromina (both are antidepressants) and selegilina (for Parkinson's disease)

Be careful ifyou take Mirtazapina Flas Bluefish with:

• antidepressants such as selective serotonin reuptake inhibitors (SSRIs), venlafaxina, and L-triptófano or triptans(used for migraines),tramadol(for pain),linezolid(an antibiotic),lithium(used to treat some psychiatric disorders),methylene blue(used to treat high levels of methemoglobin in the blood),and St. John's Wort – Hypericum perforatum(herbal medicine for depression). In rare cases, Mirtazapina Flas Bluefish alone or with these medicines, may cause the so-called serotonin syndrome. Some of the symptoms of this syndrome are: unexplained fever, sweating, palpitations, diarrhea, muscle contractions (uncontrollable), chills, exaggerated reflexes, agitation, mood changes, and loss of consciousness. If you experience a combination of these symptoms, consult your doctor immediately
• • the antidepressant nefazodona. It may increase the amount of Mirtazapina Flas Bluefish in the blood. Inform your doctor if you are taking this medicine. You may need to reduce the dose of Mirtazapina Flas Bluefish, or increase it again when you stop taking nefazodona
  • anxiety or insomnia medicinessuch as benzodiazepines
  • schizophrenia medicinessuch as olanzapina
  • allergy medicinessuch as cetirizina
  • intense pain medicinessuch as morphine

In combination with these medicines, Mirtazapina Flas Bluefish may increase the drowsiness caused by these medicines

If taken together with Mirtazapina Flas Bluefish, these medicines may reduce the amount of Mirtazapina Flas Bluefish in the blood. Inform your doctor if you are taking these medicines. You may need to increase the dose of Mirtazapina Flas Bluefish, or reduce it again when you stop taking these medicines

Mirtazapina Flas Bluefish may increase the effects of warfarina in the blood. Inform your doctor if you are taking this medicine. In case of taking them together, it is recommended that your doctor performs blood tests

Taking Mirtazapina Flas Bluefish with food, drinks, and alcohol

You may feel drowsy if you drink alcohol while taking Mirtazapina Flas Bluefish.

It is recommended not to drink any alcohol.

You can take Mirtazapina Flas Bluefish with or without food.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

The limited experience of administering Mirtazapina Flas Bluefish to pregnant women does not indicate an increased risk. However, you should be careful if you use it during pregnancy.

Inform your doctor and/or midwife that you are taking Mirtazapina Flas Bluefish. Taking during pregnancy, similar medicines (SSRIs) may increase the risk of a serious condition in newborns called persistent pulmonary hypertension of the newborn (PPHN), which causes the newborn to breathe faster and have a blue appearance. These symptoms begin in the first 24 hours after birth. If this happens to your baby, contact your doctor and/or midwife immediately.

If you become pregnant or plan to become pregnant while taking Mirtazapina Flas Bluefish, ask your doctor if you should continue taking Mirtazapina Flas Bluefish. If you are taking Mirtazapina Flas Bluefish until, or until shortly before delivery, your baby should be monitored for adverse effects.

Ask your doctor if you can breastfeed while taking Mirtazapina Flas Bluefish.

Driving and using machines

Mirtazapina Flas Bluefish may reduce your alertness and ability to concentrate. Therefore, when you start taking this medicine, make sure your faculties are not affected before driving or operating machines. If your doctor has prescribed Mirtazapina Bluefish to a patient under 18 years, make sure concentration and alertness are not affected before participating in traffic (for example, on a bicycle).

Mirtazapina Bluefish contains aspartamo (E951)

This medicine contains 3 mg, 6 mg, and 9 mg of aspartamo in each 15 mg, 30 mg, and 45 mg buccal dispersible tablet.

Aspartamo contains a source of phenylalanine that may be harmful in cases of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it correctly.

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

How much to take

The initial recommended dose is 15 or 30 mg per day..Your doctor may recommend increasing the dose after a few days to the amount that is best for you (between 15 and 45 mg per day). Normally, the dose is the same for all ages. However, if you are an older person or if you have a kidney or liver disease, your doctor may change the dose.

When to take it

Take Mirtazapina Flas Bluefish at the same time every day.

It is better to take the mirtazapine dose all at once before going to bed. However, your doctor may recommend that you divide your mirtazapine dose into morning and evening before going to bed. The highest dose should be taken before going to bed.

Take the buccal tablet in the following way

The tablets are taken orally.

1. Do not crush the buccal tablet

To avoid breaking the tablets, it is essential not to press the alveolus where it is located to remove it (Figure A).

Fig. A.

2. Separate an alveolus

Each strip contains 6 separated alveoli, separated by a perforated line. Separate an alveolus with your tablet following the perforated line (Figure 1).

Fig. 1

3. Open the alveolus

Carefully peel off the cover that covers the tablet. Start at the corner marked with an arrow (Figures 2 and 3).

Fig. 2

Fig. 3

4. Remove the buccal tablet

The buccal tablets should be removed from the alveolus with dry hands and placed on the tongue (Figure 4).

Fig. 4

The tablet will disintegrate and be swallowed afterwards with the help of water.

When to expect to feel better

Mirtazapine usually starts to take effect after 1 or 2 weeks, and after 2 to 4 weeks, you may start to feel better.

It is essential to talk to your doctor about the effects of mirtazapine during the first weeks of treatment:

→ between 2 and 4 weeks after starting to take mirtazapine, talk to your doctor about how this medication has affected you.

If you are not feeling better yet, your doctor may prescribe a higher dose. In that case, talk to your doctor again after another 2-4 weeks. Normally, you will need to take mirtazapine until the symptoms of depression have disappeared for 4-6 months.

If you take more Mirtazapina Flas Bluefish than you should

→ If you or someone takes too much mirtazapine, consult a doctor immediately.

The most likely symptoms of a mirtazapine overdose (without other medications or alcohol) are drowsiness, disorientation, and palpitations.The symptoms of a possible overdose may include changes in your heart rhythm (rapid or irregular heartbeat) and/or dizziness, which may be symptoms of a potentially life-threatening condition known as Torsades de Pointes.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or go to the nearest hospital or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take Mirtazapina Flas Bluefish

If you have to take your doseonce a day

• Do not take a double dose to compensate for the missed doses. Take the usual dose the next day.

If you have to take your dosetwice a day

• If you have forgotten the morning dose, take it with the evening dose.
• If you have forgotten the evening dose, do not take it the next morning; skip it and continue with your usual doses in the morning and evening.
• If you have forgotten both doses, do not try to recover them. Skip both doses and the next day continue with your usual doses in the morning and evening.

If you interrupt the treatment with Mirtazapina Flas Bluefish

→ Stop taking mirtazapine only if you consult your doctor.

If you stop taking it too soon, depression may reappear. When you feel better, talk to your doctor. Your doctor will decide when you can stop treatment.

Do not stop taking mirtazapine abruptly, even when depression has disappeared. If you stop taking Mirtazapina Flas Bluefish abruptly, you may feel sick, dizzy, agitated, or anxious and have headaches. These symptoms can be avoided by gradually stopping treatment. Your doctor will indicate how to gradually reduce the dose.

If you have any other doubts about the use of this product, ask your doctor or pharmacist immediately.

Like all medicines, this medicine may cause side effects, although not everyone will experience them.

Stop using mirtazapine and contact your doctor or seek medical attention immediately if you experience one of the following serious side effects.

Rare(may affect up to 1 in 100 people):

• exaggerated feeling of euphoria (mania).

Uncommon(may affect up to 1 in 1,000 people):

• yellowing of the eyes or skin, which may indicate liver dysfunction (jaundice).

Frequency not known(cannot be estimated from available data):

• signs of infection such as sudden and unexplained high fever, sore throat, and mouth sores (agranulocytosis). In rare cases, Mirtazapine Bluefish may cause bone marrow depression. Some people may become less resistant to infections because Mirtazapine Bluefish may cause a temporary decrease in white blood cells.(granulocytopenia). In rare cases, Mirtazapine Bluefish may also cause a decrease in red and white blood cells and platelets (aplastic anemia), a decrease in platelets (thrombocytopenia), or an increase in white blood cells in the blood (eosinophilia).
• seizure (convulsion)
• a combination of symptoms such as unexplained fever, sweating, palpitations, diarrhea, muscle contractions (involuntary), chills, exaggerated reflexes, agitation, mood changes, loss of consciousness, and increased salivation. In very rare cases, these symptoms may be signs of a condition called serotonin syndrome.
• thoughts of self-harm or suicide
• severe skin reactions:
• • red patches on the trunk, often with blisters in the center, skin peeling, mouth sores, throat sores, genital sores, and eye sores. These severe skin reactions may be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome, toxic epidermal necrolysis).
  • generalized erythema, high body temperature, and enlarged lymph nodes (DRESS syndrome or drug hypersensitivity syndrome).

Other possible side effects with Mirtazapine Bluefish are:

Very common(may affect more than 1 in 10 people)

• increased appetite and weight gain
• drowsiness
• headache
• dry mouth

Common(may affect up to 1 in 10 people)

• lethargy
• dizziness
• tremor
• nausea
• diarrhea
• constipation
• vomiting
• urticaria or skin rash (exanthema)
• joint or muscle pain (arthralgia or myalgia)
• back pain
• dizziness or fainting when standing up quickly (orthostatic hypotension)
• swelling (usually in ankles or feet) due to fluid retention (edema)

• fatigue
• vivid dreams
• confusion
• anxiety
• difficulty sleeping
• memory problems, which in most cases resolved when treatment was stopped.

Rare(may affect up to 1 in 100 people):

• strange sensation in the skin, such as burning, pinching, tingling, or numbness (paresthesia)
• involuntary movements of leg agitation during sleep
• fainting (syncope)
• numbness of the mouth (hypoaesthesia oral)
• low blood pressure
• nightmares
• agitation
• hallucinations
• inability to remain still

Very rare(may affect up to 1 in 1,000 people):

• tics or muscle contractions (myoclonus)
• aggression
• abdominal pain and nausea; this may involve inflammation of the pancreas (pancreatitis)

Frequency not known(cannot be estimated from available data):

• sleepwalking (somnambulism)
• abnormal sensations in the mouth (paresthesia oral)
• swelling in the mouth (buccal edema)
• swelling throughout the body (generalized edema)
• localized swelling
• severe skin reactions (dermatitis bullous, erythema multiforme)
• speech difficulties
• low sodium levels in the blood (hyponatremia)
• inadequate secretion of antidiuretic hormone
• increased levels of creatine kinase in the blood
• difficulty urinating (urinary retention)
• muscle pain, stiffness, and/or weakness, dark or discolored urine (rhabdomyolysis).
• increased levels of prolactin hormone in the blood (hyperprolactinemia, which includes symptoms of breast enlargement and/or nipple discharge)
• painful and prolonged erection of the penis.

Other side effects in children and adolescents

In children under 18 years, the following side effects were frequently observed in clinical trials: a significant weight gain, urticaria, and an increase in triglycerides in the blood.

If you consider that any of the side effects you experience are severe or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist immediately.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging and blister after CAD. The expiration date is the last day of the month indicated.

This medication does not require special conditions for conservation.

Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers of medications you no longer need. By doing so, you will help protect the environment.

Mirtazapina Flas Bluefish 30 mg buccal tablets composition

The active ingredient is mirtazapine. Each buccal tablet contains 30 mg of mirtazapine.

The other components (excipients) are: crospovidone (type B), mannitol (E421), microcrystalline cellulose, aspartame (E951), anhydrous colloidal silica, magnesium stearate, strawberry guarana flavor (maltodextrin, propylene glycol, artificial flavors, acetic acid), peppermint flavor (artificial flavors, cornstarch without gluten)

Product appearance and packaging contents

Buccal tablet.

Mirtazapina Flas Bluefish 30 mg buccal tablets are round buccal tablets printed with “37” on one face and with “A” on the other with a circular raised rim.

Mirtazapina Flas Bluefish 30 mg buccal tablets are available in perforated blisters of polyamide/aluminum/PVC/paper/polyester/aluminum with 6, 18, 30, 48, 60, 90, and 96 tablets.

Only some package sizes may be marketed.

Marketing authorization holder and manufacturer responsible

Marketing authorization holder

Bluefish Pharmaceuticals AB

P.O.Box 49013,

100 28 Stockholm

Sweden.

Manufacturer responsible

Bluefish Pharmaceuticals AB,

Gävlegatan 22,

113 30 Stockholm,

Sweden.

Local Representative

Bluefish Pharma S.L.U.,

AP 36007 2832094 Madrid, Branch 36

Spain

This medicinal product is authorized in the member states of the European Economic Area with the following names:

Last review date of this leaflet: March 2023

The detailed and updated information of this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/